Skip to main content

Re-discover the Whole Patient

  • 104 Accesses

Abstract

The innovations required to eliminate the undesirable developments described in the first part of this book are tantamount to a revolution. It is no longer a matter of optimizing a candle, but of inventing something completely new with an electric light bulb. It is not a matter of somehow improving sailboats, making them bigger or faster, but of replacing them—because their optimum has been exhausted—with something completely new, such as steam-powered ships, which are not only faster, but offer completely different possibilities for mechanical work on board. We are not only digitalizing medicine and optimizing some workflows, but we are also entering a new era of medicine, health, and prevention.

This is a preview of subscription content, access via your institution.

Buying options

eBook
USD   19.99
Price excludes VAT (USA)
  • ISBN: 978-3-030-95293-8
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   29.99
Price excludes VAT (USA)
Fig. 11.1
Fig. 11.2

Notes

  1. 1.

    Timeline: History of the Electric Car, https://www.energy.gov/timeline/timeline-history-electric-car

  2. 2.

    Stegmaier G (2020) The truth about the fuel cell. Auto Motor Sport, https://www.auto-motor-und-sport.de/tech-zukunft/alternative-antriebe/wasserstoffauto-brennstoffzelle-co2-neutral-batterie-lithium/

  3. 3.

    https://de.cloudflight.io/presse/industrie-4-0-hype-blockiert-iot-innovationen-und-digitale-produkte-24582/

  4. 4.

    Nefiodow LA (1996) The Sixth Kondratieff-Ways to Productivity and Full Employment in the Age of Information, Rhein-Sieg-Verlag, St. Augustin, 223 p., https://www.kondratieff.net/der-sechste-kondratieff; Händeler E (1997) The Sixth Kondratieff: Health becomes an economic power. Dtsch Arztebl 94:A-1116/B-948/C-891.

  5. 5.

    Petri A (2013) Google to banish death with new company, Calico. The Washington Post, https://www.washingtonpost.com/blogs/compost/wp/2013/09/18/google-to-banish-death-with-new-company-calico/; Dougherty C (2014) Calico, Google’s Anti-Aging Company, Announces New Research Facility. New York Times, https://bits.blogs.nytimes.com/2014/09/03/googles-anti-aging-company-announces-new-research-facility/?_php=true&_type=blogs&_r=0; Callaway E (2020) ‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures. Nature, https://www.nature.com/articles/d41586-020-03348-4

  6. 6.

    Jumper J et al. (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589, https://doi.org/10.1038/s41586-021-03819-2; Tunyasuvunakool K et al. (2021) Highly accurate protein structure prediction for the human proteome. Nature 596:590–596, https://doi.org/10.1038/s41586-021-03828-1

  7. 7.

    Padmanabhan S et al. (2012) Genetic basis of blood pressure and hypertension. Trends in Genetics 28:397–408, http://linkinghub.elsevier.com/retrieve/pii/S0168952512000546; Ehret GB et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478:103–109, http://www.nature.com/doifinder/10.1038/nature10405; Oikonen M (2011) Genetic variants and blood pressure in a population-based cohort: the Cardiovascular Risk in Young Finns study. Hypertension 58:1079–1085, https://hyper.ahajournals.org/content/58/6/1079.full; Miyaki K et al. (2012) The combined impact of 12 common variants on hypertension in Japanese men, considering GWAS results. Journal of Human Hypertension, 26:430–436, https://doi.org/10.1038/jhh.2011.50; Warren HR et al. (2017) Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 49:403–415 https://doi.org/10.1038/ng.3768

  8. 8.

    Weibel P et al. (2021) Hidden Patterns: Visualizing Networks at Barabasi Lab; https://www.artbook.com/9783775748629.html

  9. 9.

    Goh K-I et al. (2007) The human disease network. Proceedings of the National Academy of Sciences of the United States of America 104:8685–8690, https://doi.org/10.1073/pnas.0701361104; Barabási AL (2011) Network medicine: a network-based approach to human disease. Nat Rev. Genet 12:56–68, https://doi.org/10.1038/nrg2918; Ramsköld D et al. (2009) An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence Data. PLoS Comput Biol 5:e1000598, https://doi.org/10.1371/journal.pcbi.1000598

  10. 10.

    Bonus 3-D visualization of diseasome, https://3hwschmidt.wordpress.com/geheiltstattbehandelt/, from Barabási’s TEDMED talk, https://youtu.be/10oQMHadGos

  11. 11.

    Elbatreek MH et al. (2020) NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype. PLOS Biology 8:e3000885, https://doi.org/10.1371/journal.pbio.3000885; Casas AI et al. (2019) From single drug targets to synergistic network pharmacology in ischemic stroke. Proceedings of the National Academy of Sciences 116:7129–7136, https://doi.org/10.1073/pnas.1820799116; Casas AI et al. (2019) Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke. Journal of Clinical Investigation 129:1772–1778, https://doi.org/10.1172/JCI124283; Langhauser F et al. (2018) A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection. NPJ Systems Biology and Applications 4:8, https://doi.org/10.1038/s41540-017-0039-7; Casas AI (2017) NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage. Proceedings of the National Academy of Sciences of the United States of America 114:12315–12320, https://doi.org/10.1073/pnas.1705034114; Kleinschnitz C et al. (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biology 8;e1000479, https://doi.org/10.1371/journal.pbio.1000479

  12. 12.

    Chartier M (2017) Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects. BMC Pharmacology and Toxicology 18:18, https://doi.org/10.1186/s40360-017-0128-7

  13. 13.

    A proof-of-concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs combined with metronomic temozolomide for recurrent glioblastoma (CUSP9v3), https://www.anticancerfund.org/en/projects/combination-9-repurposed-drugs-low-dose-chemotherapy-brain-cancer, https://www.anticancerfund.org/sites/default/files/attachments/poster_sno.pdf

  14. 14.

    Sanchez-Vega F et al. (2018) Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173:321–337, e10, https://doi.org/10.1016/j.cell.2018.03.035; Ellinghaus D et al. (2016) Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nature Genetics 48:510–518, https://doi.org/10.1038/ng.3528; Kiel C et al. (2017) Simple and complex retinal dystrophies are associated with profoundly different disease networks. Scientific Reports 7:41835, https://doi.org/10.1038/srep41835

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Schmidt, H.H.H.W. (2022). Re-discover the Whole Patient. In: The end of medicine as we know it - and why your health has a future. Springer, Cham. https://doi.org/10.1007/978-3-030-95293-8_11

Download citation